Given the presence of excessive oxidative stress and the involvement of SOD1 in the pathogenesis of ALS, edaravone was initially tested in SOD1G93A mice, which slowed motor decline and SOD1 protein aggregations, promoting cell survival and inhibiting apoptosis [139, 140]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.